Literature DB >> 16309822

Patients' obstetric history in mid-trimester termination of pregnancy with gemeprost: does it really matter?

Marco Scioscia1, Antonella Vimercati, Giovanni Pontrelli, Luigi Nappi, Luigi Selvaggi.   

Abstract

OBJECTIVE: The objective was to investigate the importance of previous obstetric history for termination of pregnancy in the second-trimester with gemeprost alone. STUDY
DESIGN: A consecutive series of 423 mid-trimester inductions of abortion at our teaching hospital was reviewed. Termination of pregnancy was carried out with 1mg of vaginal gemeprost every 3h up to three doses over a 24-h period, repeated the following day if necessary. Failed induction was defined as women undelivered by 96 h. The study population was then stratified by gestational age, parity, gravidity and previous uterine scars. Main outcome parameters were failed induction and complication rates. Statistical analysis was performed using the chi(2) test or Fisher's exact test for categorical data, and the t-test and linear regression for continuous variables.
RESULTS: No significant differences were found in the primary outcome parameters with regard to the obstetric parameters considered. The failed induction rate was 1.2% with an overall incidence of complications of 7.4%. Parity was the main factor that affected clinical response (time to abortion interval and number of pessaries).
CONCLUSION: Patients' obstetric history does affect the clinical response to gemeprost, but its safety and effectiveness are preserved. These data provide clinicians with important information for correct counselling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309822     DOI: 10.1016/j.ejogrb.2005.08.031

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  1 in total

1.  Uterine rupture after prostaglandin analogues to induce midtrimester abortion.

Authors:  Elisa Maria Pappalardo; Michele La Greca; Giusi Rapisarda; Daniele Consoli
Journal:  J Prenat Med       Date:  2010-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.